Hiroshima University;The University Of Tokyo;Tokyo University of Pharmacy & Life Sciences
发明人:
申请号：
EP18844350.1
公开号：
EP3679930A1
申请日:
2018.08.06
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
An object of the invention is to develop new therapeutic agents for fatty liver disease such as NASH or NAFLD.The present invention provides therapeutic or prophylactic agents for fatty liver disease, which comprise a compound represented by following Formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The present invention also provides therapeutic or prophylactic agents for obesity, which comprise a compound represented by following Formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
